Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial

BACKGROUND: Symptom severity is the largest factor in determining subjective health in COPD. Symptoms (eg, chronic cough, dyspnea) are associated with decreased health-related quality of life (HRQoL). We evaluated the impact of arformoterol on HRQoL in COPD patients, measured by St George’s Respirat...

Descripción completa

Detalles Bibliográficos
Autores principales: Donohue, James F, Bollu, Vamsi K, Stull, Donald E, Nelson, Lauren M, Williams, Valerie SL, Stensland, Michael D, Hanania, Nicola A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804733/
https://www.ncbi.nlm.nih.gov/pubmed/29440887
http://dx.doi.org/10.2147/COPD.S141729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804733/
https://www.ncbi.nlm.nih.gov/pubmed/29440887
http://dx.doi.org/10.2147/COPD.S141729

Ejemplares similares